Novel three-dimensional bone 'mapping' software can help assess progression of osseous metastases from routine CT

Radiat Oncol. 2017 Aug 30;12(1):143. doi: 10.1186/s13014-017-0880-2.

Abstract

Imaging of bone metastasis response to therapy is a research priority. Stradwin is a new software-tool, with demonstrated sub-voxel accuracy in assessing cortical bone properties from routine CT. We applied this technology to the context of osseous metastases, with particular focus on disease progression using prostate cancer as a model. 3D-rendered 'bone-maps' were produced for 20 men with advanced prostate cancer, including a sub-cohort of 9 who had undergone serial scans. Correlation between baseline interpretation and assessments of progression between modalities was assessed. Bone-maps took significantly less time to interpret than CT bone windows (P < 0.001). Initial bone-mapping, without adjustment, demonstrated sensitivity and specificity for suspicious areas on CT of 70.7% and 73.1% respectively. Evaluating disease over time, concordance between bone-maps and current practice using RECIST outcomes was 100%.This study demonstrates the feasibility and potential use of this free post-processing software in the serial assessment of osseous metastases.

Keywords: 3-D imaging; Bone metastases; Computed tomography; Imaging techniques; Medical imaging; Prostate cancer.

MeSH terms

  • Adenocarcinoma / diagnostic imaging
  • Adenocarcinoma / secondary
  • Bone Neoplasms / diagnostic imaging*
  • Bone Neoplasms / secondary
  • Disease Progression
  • Humans
  • Image Interpretation, Computer-Assisted / methods
  • Imaging, Three-Dimensional / methods*
  • Male
  • Neoplasm Metastasis / diagnostic imaging*
  • Prostatic Neoplasms / pathology
  • Retrospective Studies
  • Software*
  • Tomography, X-Ray Computed / methods*